These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6399840)
21. [Ricin--a therapeutic agent and a biological weapon]. Høiseth G; Olsnes S Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2477-9. PubMed ID: 16186864 [TBL] [Abstract][Full Text] [Related]
22. The history of ricin, abrin and related toxins. Olsnes S Toxicon; 2004 Sep; 44(4):361-70. PubMed ID: 15302520 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of the cytotoxicity of protein toxins by a novel plant metabolite, mansonone-D. Nambiar MP; Murugesan R; Wu HC J Cell Physiol; 1998 Jul; 176(1):40-9. PubMed ID: 9618143 [TBL] [Abstract][Full Text] [Related]
27. VB4-845, a conjugated recombinant antibody and immunotoxin for head and neck cancer and bladder cancer. Biggers K; Scheinfeld N Curr Opin Mol Ther; 2008 Apr; 10(2):176-86. PubMed ID: 18386230 [TBL] [Abstract][Full Text] [Related]
28. Radioimmunoassays of abrin and ricin in blood. Godal A; Olsnes S; Pihl A J Toxicol Environ Health; 1981 Sep; 8(3):409-17. PubMed ID: 7345165 [TBL] [Abstract][Full Text] [Related]
29. [Resistance of hybridoma cells, producing antibodies against the binding subunit of plant toxin MLI, to the cytotoxic effect of this toxin]. Tonevitskiĭ AG; Shamshiev AT; Prokof'ev SA; Agapov II; Temiakov DE; Ryzhavskaia AS; Pfiuller K Mol Biol (Mosk); 1996; 30(2):416-25. PubMed ID: 8724774 [No Abstract] [Full Text] [Related]
30. Molecular imaging in cancer. Weissleder R Science; 2006 May; 312(5777):1168-71. PubMed ID: 16728630 [TBL] [Abstract][Full Text] [Related]
35. In vitro selection of aptamers that bind to ribosome-inactivating toxins. Hirao I; Yoshinari S; Yokoyama S; Endo Y; Ellington AD Nucleic Acids Symp Ser; 1997; (37):283-4. PubMed ID: 9586110 [TBL] [Abstract][Full Text] [Related]
36. Bispecific antibodies for cancer therapy. Chames P; Baty D Curr Opin Drug Discov Devel; 2009 Mar; 12(2):276-83. PubMed ID: 19333873 [TBL] [Abstract][Full Text] [Related]
37. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Morimoto H; Yonehara S; Bonavida B Cancer Res; 1993 Jun; 53(11):2591-6. PubMed ID: 7684321 [TBL] [Abstract][Full Text] [Related]
38. The mechanism of the anti-cancer activities of abrin and ricin. Tung TC; Lin JY; Hsu CT Taiwan Yi Xue Hui Za Zhi; 1974 Nov; 73(11):682-4. PubMed ID: 4532150 [No Abstract] [Full Text] [Related]
39. Synthesis and biological evaluation of novel taxoids designed for targeted delivery to tumors. Baloglu E; Miller ML; Roller EE; Cavanagh EE; Leece BA; Goldmacher VS; Chari RV Bioorg Med Chem Lett; 2004 Dec; 14(23):5885-8. PubMed ID: 15501062 [TBL] [Abstract][Full Text] [Related]
40. [Enzyme immunoassay of immune complexes formed in vitro via interactions of serum antibodies with diphtheria toxin]. Titova NG; Sviridov VV Prikl Biokhim Mikrobiol; 2005; 41(2):235-42. PubMed ID: 15859470 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]